Active Surveillance of Prostate Cancer is a Viable Option in Men Younger Than 60 Years

Uro-Oncology

The Association of Peri-Prostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active Surveillance

J Urol.

Gregg JR, Surasi DS, Childs A, Moll N, Ward JF, Kim J, Daniel CR, Logothetis C, Bathala T, Davis JW

doi: 10.1097/JU.0000000000001321.

Further Publications UrologyFurther Publications Gynecology

A phase II randomized placebo-controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance

Prostate.

Jarrard D, Filon M, Huang W, Havighurst T, DeShong K, Kim K, Konety BR, Saltzstein D, Mukhtar H, Wollmer B, Suen C, House MG, Parnes HL, Bailey HH

doi: 10.1002/pros.24076.

Uro-Oncology

Active Surveillance for Men with Intermediate Risk Prostate Cancer

J Urol.

Agrawal V, Ma X, Hu JC, Barbieri CE, Nagar H

doi: 10.1097/JU.

Uro-Oncology

Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study

Eur Urol.

Stavrinides V, Giganti F, Trock B, Punwani S, Allen C, Kirkham A, Freeman A, Haider A, Ball R, McCartan N, Whitaker H, Orczyk C, Emberton M, Moore CM

doi: 10.1016/j.eururo.2020.03.035.

Uro-Oncology

Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes

Eur Urol.

Cooperberg MR, Brooks JD, Faino AV, Newcomb LF, Kearns JT, Carroll PR, Dash A, Etzioni R, Fabrizio MD, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW, Zheng Y

doi: 10.1016/j.eururo.2018.01.017.

Uro-OncologyPregnancy and Childbirth

Qualitative study on decision-making by prostate cancer physicians during active surveillance

BJU Int.

Loeb S, Curnyn C, Fagerlin A, Braithwaite RS, Schwartz MD, Lepor H, Carter HB, Sedlander E

doi: 10.1111/bju.13651.

Uro-Oncology

Prostate Health Index and Multiparametric MRI to Predict Prostate Cancer Grade Reclassification in Active Surveillance

BJU Int.

Schwen ZR, Mamawala M, Tosoian JJ, Druskin SC, Ross AE, Sokoll LJ, Epstein JI, Carter HB, Gorin MA, Pavlovich CP

doi: 10.1111/bju.15101.

Uro-Oncology

Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance

Eur Urol.

Chesnut GT, Vertosick EA, Benfante N, Sjoberg DD, Fainberg J, Lee T, Eastham J, Laudone V, Scardino P, Touijer K, Vickers A, Ehdaie B

doi: 10.1016/j.eururo.2019.12.009.

Uro-Oncology

Prostate cancer adverse pathology reclassification in patients undergoing active surveillance in a long-term follow-up series

Prostate.

Fernández-Conejo G, Hernández V, Guijarro A, de la Peña E, Inés A, Pérez-Fernández E, Llorente C

doi: 10.1002/pros.23933.

Related content

The Association of Peri-Prostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active Surveillance

A phase II randomized placebo-controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance

Active Surveillance for Men with Intermediate Risk Prostate Cancer

Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study

Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes

Qualitative study on decision-making by prostate cancer physicians during active surveillance

Prostate Health Index and Multiparametric MRI to Predict Prostate Cancer Grade Reclassification in Active Surveillance

Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance

Prostate cancer adverse pathology reclassification in patients undergoing active surveillance in a long-term follow-up series